Literature DB >> 22810223

Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis.

Thomas Scherer1, Claudia Lindtner, Elizabeth Zielinski, James O'Hare, Nika Filatova, Christoph Buettner.   

Abstract

Insulin controls fatty acid (FA) release from white adipose tissue (WAT) through direct effects on adipocytes and indirectly through hypothalamic signaling by reducing sympathetic nervous system outflow to WAT. Uncontrolled FA release from WAT promotes lipotoxicity, which is characterized by inflammation and insulin resistance that leads to and worsens type 2 diabetes. Here we tested whether early diet-induced insulin resistance impairs the ability of hypothalamic insulin to regulate WAT lipolysis and thus contributes to adipose tissue dysfunction. To this end we fed male Sprague-Dawley rats a 10% lard diet (high fat diet (HFD)) for 3 consecutive days, which is known to induce systemic insulin resistance. Rats were studied by euglycemic pancreatic clamps and concomitant infusion of either insulin or vehicle into the mediobasal hypothalamus. Short term HFD feeding led to a 37% increase in caloric intake and elevated base-line free FAs and insulin levels compared with rats fed regular chow. Overfeeding did not impair insulin signaling in WAT, but it abolished the ability of mediobasal hypothalamus insulin to suppress WAT lipolysis and hepatic glucose production as assessed by glycerol and glucose flux. HFD feeding also increased hypothalamic levels of the endocannabinoid 2-arachidonoylglycerol after only 3 days. In summary, overfeeding impairs hypothalamic insulin action, which may contribute to unrestrained lipolysis seen in human obesity and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810223      PMCID: PMC3463338          DOI: 10.1074/jbc.M111.307348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Overfeeding rapidly induces leptin and insulin resistance.

Authors:  J Wang; S Obici; K Morgan; N Barzilai; Z Feng; L Rossetti
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

2.  FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.

Authors:  Guenther Boden; Peter Cheung; T Peter Stein; Karen Kresge; Maria Mozzoli
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-07       Impact factor: 4.310

Review 3.  Acquired and inherited lipodystrophies.

Authors:  Abhimanyu Garg
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

4.  Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.

Authors:  N Niederhoffer; B Szabo
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

5.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

6.  Hypothalamic insulin signaling is required for inhibition of glucose production.

Authors:  Silvana Obici; Bei B Zhang; George Karkanias; Luciano Rossetti
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

7.  Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.

Authors:  Lei Wang; Jie Liu; Judith Harvey-White; Andreas Zimmer; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

8.  Hypothalamic responses to long-chain fatty acids are nutritionally regulated.

Authors:  Kimyata Morgan; Silvana Obici; Luciano Rossetti
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

9.  Melanocortin-independent effects of leptin on hepatic glucose fluxes.

Authors:  Roger Gutiérrez-Juárez; Silvana Obici; Luciano Rossetti
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

10.  Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Xianqin Qu; Benjamin D Elder; Stefan Bilz; Douglas Befroy; Anthony J Romanelli; Gerald I Shulman
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

View more
  26 in total

Review 1.  Hypothalamic inflammation in obesity and metabolic disease.

Authors:  Alexander Jais; Jens C Brüning
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 2.  Insulin action and resistance in obesity and type 2 diabetes.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

Review 3.  Cardiovascular Diseases in Obesity: What is the Role of Magnesium?

Authors:  Loanne Rocha Dos Santos; Stéfany Rodrigues de Sousa Melo; Juliana Soares Severo; Jennifer Beatriz Silva Morais; Lyandra Dias da Silva; Mickael de Paiva Sousa; Thayanne Gabryelle Visgueira de Sousa; Gilberto Simeone Henriques; Dilina do Nascimento Marreiro
Journal:  Biol Trace Elem Res       Date:  2021-01-03       Impact factor: 3.738

Review 4.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 5.  New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism.

Authors:  L Cristino; L Palomba; V Di Marzo
Journal:  Int J Obes Suppl       Date:  2014-07-08

6.  Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.

Authors:  Lucia Russo; Hilda E Ghadieh; Simona S Ghanem; Qusai Y Al-Share; Zachary N Smiley; Cara Gatto-Weis; Emily L Esakov; Marcia F McInerney; Garrett Heinrich; Xin Tong; Lei Yin; Sonia M Najjar
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

7.  Short-term HFD does not alter lipolytic function of adipocytes.

Authors:  Michael Sf Wiedemann; Stephan Wueest; Alexandra Grob; Flurin Item; Eugen J Schoenle; Daniel Konrad
Journal:  Adipocyte       Date:  2014-01-08       Impact factor: 4.534

8.  Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans.

Authors:  K Alexander Iwen; Thomas Scherer; Martin Heni; Friedhelm Sayk; Toni Wellnitz; Felix Machleidt; Hubert Preissl; Hans-Ulrich Häring; Andreas Fritsche; Hendrik Lehnert; Christoph Buettner; Manfred Hallschmid
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

9.  Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action.

Authors:  Claudia Lindtner; Thomas Scherer; Elizabeth Zielinski; Nika Filatova; Martin Fasshauer; Nicholas K Tonks; Michelle Puchowicz; Christoph Buettner
Journal:  Sci Transl Med       Date:  2013-01-30       Impact factor: 17.956

10.  Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

Authors:  Andrew C Shin; Martin Fasshauer; Nika Filatova; Linus A Grundell; Elizabeth Zielinski; Jian-Ying Zhou; Thomas Scherer; Claudia Lindtner; Phillip J White; Amanda L Lapworth; Olga Ilkayeva; Uwe Knippschild; Anna M Wolf; Ludger Scheja; Kevin L Grove; Richard D Smith; Wei-Jun Qian; Christopher J Lynch; Christopher B Newgard; Christoph Buettner
Journal:  Cell Metab       Date:  2014-10-09       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.